Company: COHN
Filing Date: 2025-03-12
Form Type: 10-K
Source: 0001437749-25-007158
Chunk: 951

Company: Cohen & Co Inc.
Filing Date: 2025-03-12
Form: 10-K
Item: Item 15
Chunk 951
---
 Notes receivable   9,541      9,541    
 Interests in SPVs   12,609      12,609    
 Residential loans   132   -   132   - 
   64,327  $38,038  $26,289  $- 
 Investments measured at NAV (1)   7,890             
 Total other investments, at fair value  $72,217             
                 
 Liabilities                 
 Trading securities sold, not yet purchased:                 
 Corporate bonds and redeemable preferred stock  $24,355  $-  $24,355  $- 
 Derivatives   6,719   -   6,719   - 
 Equity securities   393   393   -   - 
 U.S. Treasury securities   34,284   34,284   -   - 
 Total trading securities sold, not yet purchased  $65,751  $34,677  $31,074  $- 
 ﻿                 
 Other investments, sold not yet purchased:                 
 Equity securities  $347  $347  $-  $- 
 Share forward liabilities   24,395   -   24,395   - 
 Total other investments, sold not yet purchased  $24,742  $347  $24,395  $- 

      (1)   As a practical expedient, the Company uses NAV (or its equivalent) to measure the fair value of its investments in the U.S. Insurance JV and the CREO JV. The U.S. Insurance JV invests in USD denominated debt issued by small insurance and reinsurance companies.  The CREO JV invests in primarily multi-family commercial real estate mortgage-backed loans. According to ASC 820, these investments are not categorized within the valuation hierarchy.   

   ﻿ 

        F-
       29

   The following provides a brief description of the types of financial instruments the Company holds, the methodology for estimating fair value, and the level within the valuation hierarchy of the estimate. The discussion that follows applies regardless of whether the instrument is included in investments-trading; other investments sold, not yet purchased; other investments, at fair value; or trading